By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PAREXEL International 

Corporate Headquarters
195 West Street
Waltham  Massachusetts  02451  U.S.A.
Phone: 781-487-9900 Fax: 781-487-0525


SEARCH JOBS

THE CLEAREST PATH TO CAREER FULFILLMENT STARTS WITH PAREXEL.

At PAREXEL, the best minds in the industry are simplifying the journey from science to new treatments—and getting them into the hands of those who need them most. If you join us, you can be a part of that. Through innovative processes and technology, your journey with us will not only be challenging but truly rewarding. PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.

Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.

PAREXEL Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates approximately 75 locations in over 50 countries around the world, and has more than 15,000 employees. For more information about PAREXEL International, visit www.PAREXEL.com.


Key Statistics


Email: info@PAREXEL.com
Ownership: Public

Web Site: PAREXEL
Employees: 15,000 worldwide
Symbol: PRXL
 









Company News
Christian Dreger Joins PAREXEL (PRXL) As Senior Vice President, PAREXEL Access And PAREXEL Consulting 9/19/2016 11:58:47 AM
PAREXEL (PRXL) To Present At Wells Fargo Healthcare Conference 9/1/2016 10:43:21 AM
PAREXEL (PRXL) Loses $160 Million in Value in One Day After Disclosing Possible 'Misappropriation of Corporate Funds' 9/1/2016 5:56:26 AM
PAREXEL International (PRXL)’s Head Of BioPharm Unit Named To The 2016 PharmaVOICE 100 8/15/2016 12:28:47 PM
PAREXEL International (PRXL) Reports Fourth Quarter and Fiscal Year 2016 Results 8/4/2016 12:00:34 PM
PAREXEL International (PRXL) Appoints Four Executives To Senior Leadership Team 8/1/2016 11:13:02 AM
PAREXEL International (PRXL) Announces Date Of Fourth Quarter And Fiscal Year 2016 Earnings Release And Conference Call 7/11/2016 8:43:25 AM
PAREXEL International (PRXL) Outlines Growth Strategy And Updates Financial Guidance At Investor Day 6/30/2016 8:55:37 AM
PAREXEL International (PRXL) Experts To Discuss Key Drug Development Insights At DIA 2016 6/20/2016 9:52:10 AM
PAREXEL International (PRXL) Invites Public To Listen To Live Webcast Of Investor Day Presentations On June 30 6/15/2016 7:41:49 AM
12345678910...
//-->